|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.7500 - 0.8700|
|52 Week Range||0.7400 - 5.8900|
|Beta (3Y Monthly)||0.39|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
MESQUITE, NV / ACCESSWIRE / September 24, 2019 / Cannabis Sativa, Inc. (CBDS) announces the offering for sale of CBDs.com, a premier domain name, for $2,500,000. "We believe that CBDs.com is the best CBD domain name available and that it has a premium value to the right buyer", stated CEO David Tobias. "CBDoil.com sold recently for $500,000, and a four-letter domain with the search engine optimization capacity of CBDs.com is certainly more desirable".
MESQUITE, NV / ACCESSWIRE / September 17, 2019 / Cannabis Sativa, Inc. (OTCQB:CBDS) is proud to announce the acquisition of CannabisSativa.com, a premier domain name. “We are excited to enhance our IP ...
MESQUITE, NV / ACCESSWIRE / July 24, 2019 / Cannabis Sativa, Inc. (OTCQB:CBDS) subsidiary PrestoDoctor, the #1 patient-rated medical cannabis telemedicine service (https://trustspot.io/store/PrestoDoctor) announces the launch of a billboard advertising campaign for medical marijuana recommendations in Oklahoma City and Tulsa, Oklahoma. “Oklahoma has been a productive market for PrestoDoctor. PrestoDoctor was recently featured on Oklahoma City’s Fox 25 television channel (https://okcfox.com/news/local/more-oklahoma-patients-getting-medical-marijuana-cards-through-online-service).
MESQUITE, NV / ACCESSWIRE / July 4, 2019 / On July 3, 2019, the profile page of Cannabis Sativa, Inc. (CBDS)(the "Company"), on www.otcmarkets.com had the Stock Promotion designation appended to its trading symbol. This was of immediate concern to the Company since the Company is not engaged in the promotion of its stock nor is it aware of any stock promotion taking place by any third party. The Company did issue a press release on July 3, 2019, updating the market on a business development within the Company.
MESQUITE, NV / ACCESSWIRE / July 3, 2019 / Cannabis Sativa, Inc. (CBDS) is proud to announce that PrestoDoctor (https://prestodoctor.com/) is now offering their online Medical recommendation services to cannabis patients in the "Show Me" state of Missouri. PrestoDoctor, the #1 patient-rated medical cannabis telemedicine service brings years of experience and compassionate telemedicine care to the emerging Missouri medical cannabis market.
MESQUITE, NV / ACCESSWIRE / June 3, 2019 / Cannabis Sativa, Inc. (CBDS) is proud to announce a signed Letter of Intent to acquire Lacuna Botanicals, a premier Colorado based CBD product line with manufacturing and distribution. "Lacuna Botanicals https://lacunabotanicals.com/ offers products designed to relax, rejuvenate and restore," said founder Jeremiah Molfese. Lacuna Botanicals bioactive creams, elixirs, oils and pet care products incorporate a wide range of botanical ingredients including terpenes, essential oils and Cannabinoids such as CBD.
MESQUITE, NV/ ACCESSWIRE / April 17, 2019 / Cannabis Sativa, Inc. (OTCQB:CBDS) is proud to announce that PrestoDoctor has expanded its telemedicine services into Oklahoma. Currently, PrestoDoctor provides cannabis patients with medical marijuana recommendations via both their online telemedicine platform and dispensary kiosks operating in California, Nevada, and New York, and will now extend their services into Oklahoma. ''PrestoDoctor offers a fast, confidential and cost-effective way for patients to become authorized medicinal marijuana users'', stated COO Rob Tankson.
MESQUITE, NV / ACCESSWIRE / April 10, 2019 / Cannabis Sativa, Inc. (OTCQB: CBDS) reports that the Company has been busy in 2018 laying the groundwork for future growth in the cannabis arena. While the Company revenue and margins grew 58% and 80%, respectively, during 2018, the $506k revenue number was far short of management's goal. CBDS' growth initiatives are focused on investments in, and partnerships with, revenue-generating, cannabis-related businesses that have management in place and are expected to be accretive within one year.
MESQUITE, NV / ACCESSWIRE / March 29, 2019 / Cannabis Sativa, Inc. (OTCQB: CBDS) is proud to announce that Independent Director Debby Goldsberry will be speaking at Cannabis Conference, in Las Vegas, NV., ...
MESQUITE, NV / ACCESSWIRE / February 4, 2019/ Cannabis Sativa, Inc. (OTCQB: CBDS) is proud to announce that PrestoDoctor founder Rob Tankson will be a featured guest at FASHINNOVATION, a platform where fashion and technology connect with a mission to inspire and share knowledge in the fashion, entrepreneurship and technology sectors, is hosting the second edition of its semi-annual conference on February 13, 2019. The all-day red carpet event takes place during NYFW at one of the city's premiere venues, Tribeca Rooftop, and features panels, live performances, installations, displays, and aims to "humanize homelessness" with the launch of a book titled: It Can Be You by The NYLON Project.
MESQUITE, NV / ACCESSWIRE / January 25, 2019 / Cannabis Sativa, Inc. (OTCQB: CBDS) is pleased to announce that Virgin Mary Jane Brand http://virginmaryjanebrand.com will be among the most innovative companies ...
While stocks have taken a beating due to trade concerns with China and rising rates, there is green at the end of the tunnel! With Congress approving the 2018 Farm Bill, stocks in the CBD space are poised to benefit and should run counter to the current market downward trends. The passage of the 2018 Farm Bill presents a tremendous opportunity for the CBD sector to continue to grow while the rest of the market shows significant volatility. Cannabidiol, or CBD, is the non-psychoactive chemical compound found in the hemp plant.
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing opportunity in the sector with the expected imminent passing of the US 2018 Farm Bill. Cabot Wealth said last week in an article, What the Farm Bill Means for Cannabis Stocks, “If the Farm Bill passes with hemp legalization intact, it could herald boom times for the CBD industry, with giant retail players like Walgreens and CVS and Walmart becoming the biggest retailers.
While stocks have taken a beating due to trade concerns with China and rising rates, there is green at the end of the tunnel! With the expected vote and passage of the 2018 Farm Bill on Monday, stocks that are in the CBD space are poised to benefit and should run counter to the current market downward trends. Stocks in the CBD and cannabis space have not been immune from the market’s downturn, but the expected passage of the bill should provide an opportunity to acquire high growth stocks in this bear market. The 2018 Farm Bill will nationally legalize the cultivation and farming of that plant.
MESQUITE, NV / ACCESSWIRE / October 25, 2018 / Cannabis Sativa, Inc. (CBDS) is pleased to announce that on October 23, 2018, the United States Patent Office issued US Patent number 10105343 titled “Cannabis based compositions and methods of treating hypertension” to Cannabis Sativa”. The marijuana lozenge invention relates to a Cannabis-based pharmaceutical composition for the treatment of hypertensive disorders by submucosal delivery comprising a pharmaceutically acceptable base and an effective amount of at least one cannabinoid or endocannabinoid containing extract of a cloned hybrid of the plant Cannabis sativa, subspecies sativa and Cannabis sativa, subspecies indica of the CTSX-ISS lineage. “CBDS acquired the rights to certain pending IP in a stock based, multimillion dollar agreement in 2014”, said President David Tobias.
MESQUITE, NV / ACCESSWIRE / October 15, 2018 / Cannabis Sativa, Inc. (CBDS) is pleased to announce that the United States Patent Office will issue to CBDS the US Patent number 10105343 titled "Cannabis based compositions and methods of treating hypertension" on October 23, 2018. "Cannabis Sativa made a bold deal acquiring this pending IP in the merger acquisition of Kush in 2014, which included Kubby Patent and Licenses. "This coconut oil based lozenge is unique because of its rapid onset and long term effects, and is based on our patented strain of cannabis, Ecuadorian Sativa", stated President David Tobias.